Study of Atezolizumab Plus BEGEV Regimen in Relapsed or Refractory Hodgkin's Lymphoma Patients
Clinical trial NCT05300282 · RECRUITING
Trial details
- NCT number
- NCT05300282
- Sponsor
- Fondazione Italiana Linfomi - ETS
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-27
- Primary completion
- 2027-04-27
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.